FFA
CTKB icon

Farther Finance Advisors’s Cytek Biosciences CTKB Stock Holding History

Farther Finance Advisors’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.67K Buy
448
+303
+209% +$1.44K ﹤0.01% 5298
2026
Q2 		$641 Sell
145
-31
-18% -$132 ﹤0.01% 5488
2026
Q1 		$788 Buy
176
+81
+85% +$382 ﹤0.01% 5167
2025
Q4 		$480 Hold
95
– – ﹤0.01% 5064
2025
Q3 		$330 Sell
95
-4,776
-98% -$17.9K ﹤0.01% 4626
2025
Q2 		$16.6K Buy
4,871
+1,629
+50% +$5.43K ﹤0.01% 2793
2025
Q1 		$12.7K Buy
3,242
+2,407
+288% +$12.5K ﹤0.01% 2617
2024
Q4 		$5.42K Sell
835
-30
-3% -$179 ﹤0.01% 2634
2024
Q3 		$4.79K Buy
865
+17
+2% +$96 ﹤0.01% 2662
2024
Q2 		$4.76K Buy
848
+41
+5% +$246 ﹤0.01% 2418
2024
Q1 		$5.41K Hold
807
– – ﹤0.01% 2035
2023
Q4 		$7.36K Buy
+807
New +$5.08K ﹤0.01% 1763

Other funds holding CTKB

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

Farther Finance Advisors's CTKB Position: Q3 2026 in Review

Farther Finance Advisors increased its Cytek Biosciences (CTKB) stake by 209% in Q3 2026, buying an estimated $1.44K and bringing the position to 448 shares worth $2.67K. The position accounts for ﹤0.01% of the portfolio, ranked #5298.

Farther Finance Advisors first reported a position in CTKB in Q4 2023 and has held it in 12 quarters since. The position peaked at $16.6K in Q2 2025. 9 funds tracked by Wall St. Rank hold CTKB as of Q3 2026.

  • Farther Finance Advisors held 448 shares of Cytek Biosciences worth $2.67K as of Q3 2026.
  • Farther Finance Advisors bought 303 Cytek Biosciences shares in Q3 2026, an estimated $1.44K.
  • Cytek Biosciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5298 holding.
  • Farther Finance Advisors first reported a position in Cytek Biosciences in Q4 2023 and has held it in 12 quarters since.
  • Farther Finance Advisors's Cytek Biosciences position peaked at $16.6K in Q2 2025.
  • 9 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.